Loading…

Evaluating the inhibitory priority of Bcl‐xL to Bad, tBid and Bax by using live‐cell imaging assay

Molecular regulatory network among the B cell leukemia‐2 (Bcl‐2) family proteins is a research hotspot on apoptosis. The inhibitory priority of anti‐apoptotic Bcl‐2 family proteins (such as Bcl‐xL) to pro‐apoptotic Bcl‐2 family proteins (such as Bad, tBid and Bax) determines the outcome of their int...

Full description

Saved in:
Bibliographic Details
Published in:Cytometry. Part A 2021-11, Vol.99 (11), p.1091-1101
Main Authors: Wu, Ge, Tu, Zhuang, Yang, Fangfang, Mai, Zihao, Chen, Hongce, Tang, Qiling, Ye, Xianxin, Wang, Kunhao, Wang, Xiaoping, Chen, Tongsheng
Format: Article
Language:English
Subjects:
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Molecular regulatory network among the B cell leukemia‐2 (Bcl‐2) family proteins is a research hotspot on apoptosis. The inhibitory priority of anti‐apoptotic Bcl‐2 family proteins (such as Bcl‐xL) to pro‐apoptotic Bcl‐2 family proteins (such as Bad, tBid and Bax) determines the outcome of their interactions. Based on over‐expression model system, we here evaluate the inhibitory priority of Bcl‐xL to Bad, tBid and Bax by using live‐cell imaging assay on cell viability. Fluorescence images of living cells co‐expressing CFP‐Bcl‐xL and YFP‐Bad or YFP‐tBid or YFP‐Bax showed that Bcl‐xL markedly inhibited Bad/tBid/Bax‐mediated apoptosis, revealing that Bcl‐xL inhibits the proapoptotic function of Bad, tBid and Bax. In the case of equimolar co‐expression of Bad and CFP‐Bcl‐xL, the inhibition of Bcl‐xL on tBid/Bax mediate‐apoptosis was completely relieved. Moreover, co‐expression of tBid‐P2A‐CFP‐Bcl‐xL significantly relieved the inhibition of Bcl‐xL on the pro‐apoptotic ability Bax, suggesting that Bcl‐xL preferentially inhibits the pro‐apoptotic ability of Bad over tBid, subsequently to Bax.
ISSN:1552-4922
1552-4930
DOI:10.1002/cyto.a.24351